StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) stock

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$16.14+0.27 (+1.70%)

Close on Nov 13, 2026Market cap $1.03BP/E –Yield –

Jade Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for Jade Biosciences

Jade Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jade Biosciences figures

See a number that looks wrong?